This is the first study to present a comprehensive set of clinical and experimental evidence establishing CTHRC1 as an oncogenic factor that facilitates ESCC tumour progression and metastasis, resulting in poor prognosis. The gene discussed is CTHRC1; the disease is esophageal squamous cell carcinoma.